Search
Third ‘i4MDS’ consortium general meeting held in The Hague
The International Integrative Innovative Immunology for Myelodysplastic Neoplasms ('i4MDS') consortium held its third general meeting in The Hague from February 7–8, 2025.
Read moreEHA Research Mobility Grants
The call for applications is currently closed
EHA strives to develop the career of young scientists by supporting mobility and facilitating a visit to a research group in another institute.
EHA-Baltic Hematology Tutorial on Bleeding Disorders & Thrombosis
Dates: August 28-30, 2020
Location: Riga, Latvia
Chairs: S Eichinger (EHA) & S Lejniece (LASH)
After a successful first edition, EHA is once again collaborating with the Latvian Society of Hematology (LASH), the Estonian Society of Hematology (EHS) and the Lithuanian Society of Hematology…
Highlights of Past EHA (HOPE) Asia 2020
EHA is returning to Sri Lanka for the 2nd edition of the Highlights of Past EHA (HOPE) Asia, organized with our hosting partner: the Sri Lanka College of Haematologists (SLCH).
Read moreHighlights of Past EHA (HOPE) Asia 2021
For the third edition of the Highlights of Past EHA (HOPE) Asia, EHA will organize a truly regional meeting by collaborating simultaneously with our hematology partners from the region.
Read moreEHA-SAH Hematology Tutorial on Acute Leukemia, MDS and BMF
Dates: September 11-12, 2020
Location: Buenos Aires, Argentina
Chairs: G Stemmelin, G Ossenkoppele
The third EHA-SAH Hematology Tutorial will be held in Buenos Aires, Argentina.
Grants & abstract awards
EHA Travel GrantsThe call for travel grant applications closed on March 1, 2025 (23:59 CET). The grants will only be available for investigators with accepted abstracts, submitted during the regular abstract submission.
Read moreAbstract submission
Abstract procedureThe official abstract submission closed on March 1, 2025 (23:59 CET).
Read moreLate-Breaking Abstract Submission
Late-breaking abstract procedureThe official late-breaking abstract submission will open from May 2 to 9, 2025 (09:00 CEST). The full late-breaking abstract submission terms & conditions can be found here.
Read more- «
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- »